9,850 followers
In India, several centres have been using low dose Rituximab in the Rx of pry MN. Here is a study from AIIMS Delhi https://t.co/WM5h8KbrHy #NephJC https://t.co/urKjVa5HfI
In India, several centres have been using low dose Rituximab in the Rx of pry MN. Here is a study from AIIMS Delhi https://t.co/WM5h8KbrHy #NephJC https://t.co/urKjVa5HfI
Low-dose Rituximab therapy in resistant idiopathic membranous nephropathy: single-center experience https://t.co/5E6nrGYNvH
@M_Elraggal We had a series of patients where we initially tried this 👇 https://t.co/iAkYeLRkkq
RT @CKJsocial: Low-dose #Rituximab therapy in resistant idiopathic membranous #nephropathy: single-center experience https://t.co/GAzvpbJbm…